Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Operating Margin (2020 - 2025)

Historic Operating Margin for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to 3468.59%.

  • Pliant Therapeutics' Operating Margin changed N/A to 3468.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 7681.22%, marking a year-over-year change of. This contributed to the annual value of 11654.75% for FY2023, which is 103413800.0% down from last year.
  • Per Pliant Therapeutics' latest filing, its Operating Margin stood at 3468.59% for Q3 2025.
  • Pliant Therapeutics' 5-year Operating Margin high stood at 7376.1% for Q1 2025, and its period low was 19083.87% during Q2 2023.
  • Its 4-year average for Operating Margin is 1378.83%, with a median of 1280.27% in 2021.
  • As far as peak fluctuations go, Pliant Therapeutics' Operating Margin surged by 6861200bps in 2022, and later plummeted by -184897200bps in 2023.
  • Over the past 4 years, Pliant Therapeutics' Operating Margin (Quarter) stood at 1230.57% in 2021, then tumbled by -55bps to 1903.31% in 2022, then plummeted by -903bps to 19083.87% in 2023, then skyrocketed by 118bps to 3468.59% in 2025.
  • Its Operating Margin was 3468.59% in Q3 2025, compared to 5635.6% in Q2 2025 and 7376.1% in Q1 2025.